Gene therapy Archives

Gene therapy: can CDMOs solve the manufacturing bottleneck?

The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies, are playing an increasing role in the development of biologics. But the growing need for viral vectors and their plasmid building blocks have resulted in a manufacturing bottleneck. Can contract manufacturing organizations cope with the rising demand? In 2019, Zolgensma, a […]

June 7, 2022 - 7 minutesmins - By Ute Boronowsky

News and Trends 31 May 2022

Therapeutic RNA company receives additional funding

UK biotech company Transine Therapeutics, which is developing a novel class of therapeutic RNAs, has successfully raised £4.6M ($5.8M) in additional seed funding. The financing was led by new investor Epidarex Capital with participation from existing investor the Dementia Discovery Fund (DDF). Transine said the additional funds will enable it to further develop its SINEUP […]

May 31, 2022 - 2 minutesmins - By Jim Cornall

In Depth 4 Apr 2022

Portable Sequencing Is Reshaping Genetics Research

Portable sequencing is making it possible for biologists to perform DNA analysis anywhere in the world. How is this technology reshaping the way they work? Thanks to nanopore technology, scientists can now collect samples and sequence them anywhere. It is the concept of backpacking applied to scientific research. French molecular biologist Anne-Lise Ducluzeau has experienced […]

April 4, 2022 - 11 minutesmins - By Carlos de Rojas

gene therapy bacteria ilya pharma lactic acid

News and Trends 23 Mar 2022

Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding

Cell and gene therapies are taking off in a big way in Europe. As the buzz grows, the Swedish firm Ilya Pharma has raised €8.5M to lay down the foundations of bacterial gene therapies for enterocolitis and diabetic ulcers. Investor interest in cell and gene therapy is ramping up fast around the world, with a […]

March 23, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 16 Feb 2022

Startup Bags €50M Series A to Smash Gene Therapy Vector Limits

After closing Spain’s largest biopharma Series A round, the company SpliceBio has set its foundations in the gene therapy field and joins the push to deliver bigger therapeutic genes into patients. SpliceBio was founded in 2012 to tinker with a type of protein called inteins, which can stick peptides together to form new proteins. The […]

February 16, 2022 - 5 minutesmins - By Jonathan Smith

Gene therapy genenta science genflow biosciences

News and Trends 21 Jan 2022

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science and Genflow Biosciences. The firms aim to shine as biotech stocks elsewhere perform poorly. Until recently, European gene therapy companies were going through a dry spell in terms of launching initial public offerings (IPO). The […]

January 21, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 14 Jan 2022

Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021

Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European firms missed out on the funding growth. Companies around the world developing cell and gene therapies raised €20.1B ($23.1B) over 2021, said the advanced therapy advocacy organization the Alliance for Regenerative Medicine (ARM) in a briefing this week. This bumper […]

January 14, 2022 - 6 minutesmins - By Jonathan Smith

Best in Biotech 22 Dec 2021

The Biggest European Biotech News of 2021

In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has emerged stronger than ever this year. These were the key moments for the sector in 2021. The year 2021 has seen skyrocketing fortunes for many European biotech players. Investment firms, for instance, raised far more funding than in 2020, which […]

December 22, 2021 - 10 minutesmins - By Jonathan Smith

In Depth 22 Nov 2021

How Will We Be Treating Cystic Fibrosis 10 Years From Now?

Current treatments for cystic fibrosis are not suitable for all patients and have a limited effect on this life-threatening disease. But new advances in the field promise to overcome these hurdles. The cause of cystic fibrosis is very straightforward. Its treatment, however, is not. People diagnosed with cystic fibrosis have a mutation in a gene […]

November 22, 2021 - 9 minutesmins - By Clara Rodríguez Fernández

treatments, biotech, genes, biomanufacturing, infographic

Infographics by 15 Nov 2021

Gene therapy: Making Rare Disease Therapies Less Rare

While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide. Many rare conditions are chronic, progressive, and life-threatening with limited treatment options available. Advances in gene therapy provide hope to actual cures and could revolutionize treatment prospects for patients with rare genetic diseases. This infographic shows how we can unlock […]

November 15, 2021 - 2 minutesmins - By External Contributor

News and Trends 4 Nov 2021

Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing

Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of these therapies is held back by skill shortages. Increasing training programs and automation could form the solution. The cell and gene therapy fields enjoyed their best-ever funding yield in the first half of 2021, with €12.2B ($14.1B) netted globally. However, […]

November 4, 2021 - 5 minutesmins - By Anita Chakraverty

Plasmids: How to Solve a Bottleneck in Scalable Gene Therapy Manufacturing?

As gene therapies become increasingly successful, companies are in a competitive race to deliver manufacturing technologies that can streamline large-scale production at reduced costs and faster turnaround times. However, plasmids, the building blocks of viral vectors, remain a bottleneck in gene therapy manufacturing. Two companies have united to provide exciting alternatives. With over 2,400 gene […]

October 26, 2021 - 7 minutesmins - By Letícia Manosso

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us